Anti-SUMF1/ AAPA3037/ FGE functional antibody

Anti-SUMF1/ AAPA3037/ FGE functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SUMF1/SUMF1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0493-Ab-1/ GM-Tg-hg-SE0493-Ab-2Anti-Human SUMF1 monoclonal antibodyHuman
GM-Tg-rg-SE0493-Ab-1/ GM-Tg-rg-SE0493-Ab-2Anti-Rat SUMF1 monoclonal antibodyRat
GM-Tg-mg-SE0493-Ab-1/ GM-Tg-mg-SE0493-Ab-2Anti-Mouse SUMF1 monoclonal antibodyMouse
GM-Tg-cynog-SE0493-Ab-1/ GM-Tg-cynog-SE0493-Ab-2Anti-Cynomolgus/ Rhesus macaque SUMF1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0493-Ab-1/ GM-Tg-felg-SE0493-Ab-2Anti-Feline SUMF1 monoclonal antibodyFeline
GM-Tg-cang-SE0493-Ab-1/ GM-Tg-cang-SE0493-Ab-2Anti-Canine SUMF1 monoclonal antibodyCanine
GM-Tg-bovg-SE0493-Ab-1/ GM-Tg-bovg-SE0493-Ab-2Anti-Bovine SUMF1 monoclonal antibodyBovine
GM-Tg-equg-SE0493-Ab-1/ GM-Tg-equg-SE0493-Ab-2Anti-Equine SUMF1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0493-Ab-1/ GM-Tg-hg-SE0493-Ab-2; GM-Tg-rg-SE0493-Ab-1/ GM-Tg-rg-SE0493-Ab-2;
GM-Tg-mg-SE0493-Ab-1/ GM-Tg-mg-SE0493-Ab-2; GM-Tg-cynog-SE0493-Ab-1/ GM-Tg-cynog-SE0493-Ab-2;
GM-Tg-felg-SE0493-Ab-1/ GM-Tg-felg-SE0493-Ab-2; GM-Tg-cang-SE0493-Ab-1/ GM-Tg-cang-SE0493-Ab-2;
GM-Tg-bovg-SE0493-Ab-1/ GM-Tg-bovg-SE0493-Ab-2; GM-Tg-equg-SE0493-Ab-1/ GM-Tg-equg-SE0493-Ab-2
Products NameAnti-SUMF1 monoclonal antibody
Formatmab
Target NameSUMF1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SUMF1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0493-Ag-1Recombinant multi-species SUMF1/ AAPA3037/ FGE protein
    ORF Viral VectorpGMLP002817human SUMF1 Lentivirus plasmid
    ORF Viral VectorvGMLP002817human SUMF1 Lentivirus particle
    ORF Viral VectorpGMLPm002787mouse Sumf1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002787mouse Sumf1 Lentivirus particle


    Target information

    Target IDGM-SE0493
    Target NameSUMF1
    Gene ID285362,58911,362409,704112,484681,101100288,536435,100052857
    Gene Symbol and SynonymsAAPA3037,FGE,SUMF1,UNQ3037
    Uniprot AccessionQ8NBK3,Q0P5L5
    Uniprot Entry NameSUMF1_HUMAN,SUMF1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000144455
    Target ClassificationN/A

    The target: SUMF1, gene name: SUMF1, also named as AAPA3037, FGE, UNQ3037. This gene encodes an enzyme that catalyzes the hydrolysis of sulfate esters by oxidizing a cysteine residue in the substrate sulfatase to an active site 3-oxoalanine residue, which is also known as C-alpha-formylglycine. Mutations in this gene cause multiple sulfatase deficiency, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.